文献速递MDS 与骨髓增殖性肿瘤

CADM1 肿瘤抑制基因是 11q 缺失型 MDS 的主要候选基因

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
PubMed 文献 · Blood Adv · 2022-01-01

该研究纳入 113 例携带 del(11q) 的 MDS 或 MDS/MPN 患者,在临床、细胞、遗传及分子层面进行分析。结果显示女性多见、单核细胞低、巨核系发育异常,共同缺失区位于 11q23.2 的 CADM1 与 NXPE2 之间基因间区,CADM1 在所有受检髓系细胞表达。小鼠 Cadm1 缺失改变骨髓淋系/髓系比例,但不影响多系重建潜能,提示 CADM1 可能参与 del(11q) MDS 病理生理。

要点

  • del(11q) MDS 呈女性优势、单核细胞低及巨核系发育异常。
  • 共同缺失区位于 11q23.2 的 CADM1 与 NXPE2 基因间区。
  • CADM1 表达于全部受检髓系细胞,而 NXPE2 不表达。

核心结论

  • CADM1 可能是 del(11q) MDS 的重要候选肿瘤抑制基因,其作用从实体瘤扩展至造血系统恶性肿瘤。

研究设计与样本

  • 研究纳入 113 例携带 del(11q) 的 MDS 或 MDS/MPN 患者,进行临床、细胞、细胞遗传及分子层面分析。
  • 利用小鼠 Lineage-Sca1+Kit+ 细胞进行 Cadm1 缺失的功能研究,并开展同基因移植实验。

主要发现

  • del(11q) MDS 呈女性优势,生存预后与其他 MDS 相似,单核细胞计数低,伴巨核系发育异常。
  • 多数病例 del(11q) 为孤立、原发且为累及 11q22-23 区域的中间缺失,该区域包含 ATM、KMT2A 和 CBL 基因。
  • 共同缺失区位于 11q23.2 的 CADM1 与 NXPE2 之间基因间区,CADM1 在所有受检髓系细胞表达,NXPE2 不表达。
  • 小鼠 Cadm1 缺失改变骨髓淋系/髓系比例,但不改变同基因移植后的多系造血重建潜能。
  • 常见同时缺失 KMT2A、ATM、CBL,并伴 ASXL1、SF3B1、CBL 突变。

临床怎么用

  • 对 del(11q) MDS 应关注女性、单核细胞低及巨核系发育异常等临床细胞特征。
  • 分子检测可关注 11q23.2 区域及 CADM1、KMT2A、ATM、CBL 等基因状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis leading to peripheral cytopenias and in a substantial proportion of cases to acute myeloid leukemia. The deletion of the long arm of chromosome 11, del(11q), is a rare but recurrent clonal event in MDS. Here, we detail the largest series of 113 cases of MDS and myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) harboring a del(11q) analyzed at clinical, cytological, cytogenetic, and molecular levels. Female predominance, a survival prognosis similar to other MDS, a low monocyte count, and dysmegakaryopoiesis were the specific clinical and cytological features of del(11q) MDS. In most cases, del(11q) was isolated, primary and interstitial encompassing the 11q22-23 region containing ATM, KMT2A, and CBL genes. The common deleted region at 11q23.2 is centered on an intergenic region between CADM1 (also known as Tumor Suppressor in Lung Cancer 1) and NXPE2. CADM1 was expressed in all myeloid cells analyzed in contrast to NXPE2. At the functional level, the deletion of Cadm1 in murine Lineage-Sca1+Kit+ cells modifies the lymphoid-to-myeloid ratio in bone marrow, although not altering their multilineage hematopoietic reconstitution potential after syngenic transplantation. Together with the frequent simultaneous deletions of KMT2A, ATM, and CBL and mutations of ASXL1, SF3B1, and CBL, we show that CADM1 may be important in the physiopathology of the del(11q) MDS, extending its role as tumor-suppressor gene from solid tumors to hematopoietic malignancies.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lafage-Pochitaloff M, Gerby B, Baccini V, et al. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11. Blood Adv. 2022. PMID: 34638130. doi:10.1182/bloodadvances.2021005311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。